Aug 11, 7:10 AMSecurities fraud class action filed against Embecta alleging it misled investors on insulin pen needle product strength
Index
RUT
Market Cap
288.68M
Enterprise Value
1.57B
Income
87.50M
Sales
1.02B
Book/sh
-10.81
Cash/sh
3.85
Employees
1850
IPO
Mar 22, 2022
P/E
3.43
Forward P/E
2.89
PEG
-
P/S
0.28
P/B
-
P/C
1.32
P/FCF
1.75
EV/EBITDA
4.86
EV/Sales
1.54
Quick Ratio
1.17
Current Ratio
1.68
Debt/Eq
-
LT Debt/Eq
-
Option/Short
Yes / Yes
EPS (ttm)
1.48
EPS next Y
1.76
EPS next Q
0.29
EPS this Y
-37.80%
EPS next Y
-3.95%
EPS next 5Y
-12.89%
EPS past 3/5Y
-25.52% -
Sales past 3/5Y
-1.47% -0.10%
EPS Y/Y TTM
4.11%
Sales Y/Y TTM
-7.60%
EPS Q/Q
-53.64%
Sales Q/Q
-8.05%
Insider Own
7.85%
Insider Trans
2.65%
Inst Own
83.68%
Inst Trans
-13.19%
ROA
7.22%
ROE
-
ROIC
11.83%
Gross Margin
59.63%
Oper. Margin
26.38%
Profit Margin
8.59%
SMA20
33.03%
SMA50
46.87%
SMA200
-39.31%
Trades
Shs Outstand
56.66M
Shs Float
52.21M
52W High
15.55 -67.23%
52W Low
2.77 83.94%
Volatility
11.22% 6.25%
ATR (14)
0.31
RSI (14)
74.06
Beta
0.86
Rel Volume
0.95
Avg Volume
2.08M
Volume
1,407,923
Perf Week
45.57%
Perf Month
58.23%
Perf Quarter
63.30%
Perf Half Y
-49.35%
Perf YTD
-57.11%
Perf Year
-63.45%
Perf 3Y
-75.54%
Perf 5Y
-
Perf 10Y
-
Prev Close
4.75
Price
5.09
Change %
7.26%
Date Action Analyst Rating Change Price Target Change
May-06-26Downgrade BTIG Research Buy → Neutral
Apr-10-25Initiated Mizuho Neutral $15
Dec-02-24Upgrade Morgan Stanley Underweight → Equal-Weight $13 → $20
Nov-27-24Upgrade BTIG Research Neutral → Buy $26
Oct-20-23Initiated Wolfe Research Peer Perform
Jan-06-23Downgrade Morgan Stanley Equal-Weight → Underweight $28
Sep-08-22Initiated BTIG Research Neutral
Aug-01-22Initiated Morgan Stanley Equal-Weight $33
Jun-21-22Initiated BofA Securities Underperform $25
Today 04:24AM
Aug-11-26 07:07AM
Aug-10-26 07:00AM
Aug-08-26 08:30AM
Aug-07-26 03:00PM
06:30AM Loading…
06:30AM
06:00AM
Jul-27-26 07:30PM
04:40AM
Jul-23-26 05:00PM
Jul-21-26 08:30AM
Jun-25-26 05:23AM
Jun-18-26 10:36AM
Jun-16-26 06:30AM
Jun-05-26 07:25PM
05:00PM Loading…
Jun-01-26 05:00PM
May-21-26 08:20PM
May-18-26 07:13AM
07:10AM
May-15-26 09:00AM
May-08-26 09:00AM
May-05-26 04:53PM
06:30AM
06:30AM
Apr-21-26 05:00PM
Mar-20-26 06:35AM
Mar-19-26 10:37AM
06:30AM
Feb-11-26 04:10PM
Feb-05-26 05:30PM
02:02PM Loading…
02:02PM
06:30AM
06:00AM
Jan-22-26 05:00PM
Dec-18-25 05:00PM
Nov-25-25 02:01PM
06:30AM
06:00AM
Nov-20-25 07:50AM
Nov-17-25 05:00PM
Nov-14-25 06:30AM
Nov-11-25 05:00PM
Oct-06-25 05:15AM
Sep-15-25 08:06AM
05:37AM
Sep-09-25 04:12AM
Aug-26-25 05:00PM
Aug-25-25 09:30AM
Aug-12-25 09:55AM
Aug-09-25 03:03AM
Aug-08-25 06:30AM
06:00AM
Jul-24-25 05:00PM
Jul-13-25 12:27AM
Jul-10-25 11:13AM
May-27-25 05:00PM
May-22-25 06:30AM
May-13-25 10:50AM
May-10-25 05:16AM
03:03AM
May-09-25 12:10PM
07:40AM
06:30AM
06:00AM
May-08-25 05:15PM
May-07-25 11:35AM
Apr-28-25 07:30AM
Apr-22-25 03:51AM
Apr-21-25 05:00PM
Apr-01-25 08:05AM
Feb-19-25 03:36PM
Feb-18-25 05:00PM
Feb-07-25 02:09AM
Feb-06-25 07:45AM
06:30AM
06:00AM
Jan-23-25 05:00PM
Dec-19-24 05:00PM
Dec-09-24 08:50AM
Dec-06-24 06:00AM
Nov-27-24 06:40AM
02:02AM
12:26AM
Nov-26-24 01:15PM
07:40AM
06:40AM
06:30AM
06:00AM
Nov-18-24 10:00AM
Nov-12-24 05:31PM
05:00PM
Nov-07-24 06:30AM
Sep-03-24 07:55AM
06:30AM
Aug-22-24 05:00PM
Aug-12-24 09:35AM
09:30AM
Aug-10-24 08:18AM
Aug-09-24 10:52AM
07:40AM
Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.
PresidentMr. Devdatt Kurdikar Ph.D.
Senior VP & CFOMr. Jacob P. Elguicze
Senior VPMr. Jeffrey Z. Mann
Senior VP & Chief Human Resources OfficerMs. Jean M. Casner
Senior Vice President of Global Manufacturing & Supply ChainMr. Shaun Curtis
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kurdikar DevdattPresident and CEOAug 12 '26Buy4.7030,000140,937804,919Aug 13 10:50 AM
Elguicze JacobSVP and CFOAug 12 '26Buy4.6720,00093,360309,139Aug 13 10:48 AM
Mann Jeffrey ZPres, Pharm Svc&Prod Mgmt, CLOAug 12 '26Buy4.9920,00099,800262,915Aug 13 10:47 AM
HOMBACH ROBERT J.DirectorAug 12 '26Buy4.9745,000223,848109,587Aug 13 10:45 AM